MotherToBaby Profile Banner
MotherToBaby Profile
MotherToBaby

@MotherToBaby

Followers
2K
Following
3K
Media
4K
Statuses
12K

Evidence-based info about exposures in pregnancy & breastfeeding by 📲💬📧💻. #AskTheExperts https://t.co/Qo3SO5rMDN

North America
Joined May 2010
Don't wanna be here? Send us removal request.
@MotherToBaby
MotherToBaby
15 hours
MotherToBaby is currently enrolling pregnant people in an observational study looking at the Tdap (tetanus, diphtheria, and pertussis) vaccine. All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
2 days
MotherToBaby is currently enrolling pregnant people in an observational study looking at Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
2 days
MotherToBaby Pregnancy Studies is thrilled to be part of the #SDPAFall2025 Exhibit Hall in San Antonio! Stop by our booth and see what’s new in the world of dermatology innovation. - 🔗
0
0
0
@MotherToBaby
MotherToBaby
3 days
MotherToBaby is currently enrolling people in an observational study to learn about Motegrity® (prucalopride) during pregnancy. All studies are conducted through phone interviews—no changes to your current medications or travel are required. Learn more ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
3 days
MotherToBaby Pregnancy Studies & Mommy’s Milk is here at #ACG2025 in Phoenix, AZ! Stop by Booth 665 to meet us, learn about our research, and pick up free resources.
0
0
0
@MotherToBaby
MotherToBaby
3 days
Attending ACR 2025 in Chicago?! Stop by booth 2231-NP to say hello to MotherToBaby Pregnancy Studies!!! - #ACR2025 #MotherToBaby
0
0
0
@MotherToBaby
MotherToBaby
4 days
MotherToBaby is currently enrolling pregnant women in an observational study looking at Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
5 days
MotherToBaby is currently enrolling pregnant people in observational studies looking at Tremfya® (guselkumab) and Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
9 days
MotherToBaby is currently enrolling pregnant people in an observational study looking at the BOOSTRIX Tdap vaccine. All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
11 days
MotherToBaby is currently enrolling people in an observational study to learn about Benlysta® (belimumab) during pregnancy. All studies are conducted through phone interviews—no changes to your current medications or travel are required. Learn more ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
12 days
MotherToBaby is currently enrolling pregnant people in an observational study looking at Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/uVJrEm2rE1
0
0
0
@MotherToBaby
MotherToBaby
19 days
MotherToBaby is currently enrolling pregnant people in an observational study looking at Tremfya® (guselkumab). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
24 days
MotherToBaby is currently enrolling pregnant people in an observational study looking at Kesimpta® (ofatumumab) (US PATIENTS ONLY). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
25 days
MotherToBaby is currently enrolling pregnant women in an observational study looking at Tremfya® (guselkumab). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
1
@MotherToBaby
MotherToBaby
27 days
MotherToBaby is currently enrolling pregnant people in observational studies looking at eczema (moderate to severe atopic dermatitis). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/uVJrEm2rE1
0
0
0
@MotherToBaby
MotherToBaby
1 month
MotherToBaby is currently enrolling pregnant people in observational studies looking at Tremfya® (guselkumab) and Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
1 month
MotherToBaby is currently enrolling pregnant women in an observational study looking at Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
1 month
MotherToBaby is currently enrolling pregnant people in an observational study looking at the Tdap (tetanus, diphtheria, and pertussis) vaccine. All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
1 month
MotherToBaby is currently enrolling people in an observational study to learn about Motegrity® (prucalopride) during pregnancy. All studies are conducted through phone interviews—no changes to your current medications or travel are required. Learn more ➡️ https://t.co/9czpuSLD8c
0
0
0
@MotherToBaby
MotherToBaby
1 month
MotherToBaby is currently enrolling pregnant people in an observational study looking at Bimzelx® (bimekizumab-bkzx). All studies are conducted through phone interviews—no changes to normal treatment or travel required. ➡️ https://t.co/uVJrEm2rE1
0
0
1